Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Mature
Primary summary from verified readiness
- Confidence
- 62% · fresh
- Computed at
- 2026-09-22T00:12:02.910266+00:00
- Claimed
- 100
- Reported
- 95
- Verified
- 85
- Gap
- +15
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Track; not yet
- Why
- FDA-verified approval and a randomized Phase 3 survival benefit make this a notable therapeutic technology. Safety, affordability, resistance and broader-indication evidence remain important uncertainties for clinical-intelligence tracking.
- Next
- Track post-launch real-world evidence, payer coverage, resistance patterns and combination-trial results for future register updates, including expansion to other RAS-driven cancers.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 0
- Tier 2
- 3
- Tier 3
- 3
- Supports
- 4
- Contradicts
- 2
- Context
- 0
- Latest observed
- 2026-08-26
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-09-21 Reading moved from mature to mature.